arrow
C

Cesar M. Castro

massachusetts general hospital research institute
H指数:43
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Blood-based RNA biomarker for the early detection of ovarian cancer

基于血液的RNA生物标志物用于卵巢癌的早期检测

2026-11-100
PRE
Hypoxia induced VEGF secretion promotes resistance to bispecific T-cell engagers

缺氧诱导的VEGF分泌促进对双特异性T细胞衔接器的抵抗

2025-12-190
OAAI
Letrozole, abemaciclib and metformin in endometrial cancer: a non-randomized phase 2 trial

来曲唑、阿贝西利和二甲双胍在子宫内膜癌中的应用:一项非随机性Ⅱ期临床试验

2025-12-030
OAAI
Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)–targeting antibody-drug conjugate (ADC), in combination with pembrolizumab in patients with platinum-resistant ovarian cancer

mirvetuximab soravtansine(一种靶向叶酸受体α(FRα)的抗体偶联药物,ADC)与pembrolizumab联合治疗铂耐药性卵巢癌患者的安全性与有效性

2025-07-220
PRE
Amplifying mutational profiling of extracellular vesicle mRNA with SCOPE

具有范围的细胞外囊泡mRNA的扩增突变图谱

2024-10-070
PRE
Extrinsic and intrinsic preanalytical variables affecting liquid biopsy in cancer

影响癌症液体活检的外在和内在分析前变量

2023-10-0113
OAAI
The Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoring

液体活检联盟:癌症早期检测与监测的挑战与机遇

2023-10-0138
OAAI
Inaugurating High-Throughput Profiling of Extracellular Vesicles for Earlier Ovarian Cancer Detection

用于早期卵巢癌检测的细胞外囊泡的高通量分析

2023-07-2313
OAAI